N/A
Completed N=100
Impact of Adherence to Treatment in Asthma Control
Source: ClinicalTrials.gov NCT01455545 ↗Enrolled (actual)
100
Serious AEs
—
Results posted
Aug 2013
Primary outcomePrimary: Analyze How Adherence to Treatment Using ASK-20 Questionnaire Influences Level of Asthma Control. — 34; 32 units on a scale — p=0.967
Summary
This survey aims to analyze how adherence to treatment, using Ask-20 questionnaire and prescription count, influences level of asthma control in a sample of patients with severe and moderate-mild asthma.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Analyze How Adherence to Treatment Using ASK-20 Questionnaire Influences Level of Asthma Control. |
34; 32 | 0.967 |
| PRIMARY Analyze How Adherence to Treatment Using Prescription Account Influences Level of Asthma Control. |
33; 26; 22; 19 | 0.822 |
| SECONDARY Fraction Exhaled of Nitric Oxide (FeNO) According to Level of Asthma Control. |
27; 28 | 0.861 |
| SECONDARY Gender According to Level of Asthma Control. |
16; 18; 39; 27 | 0.252 |
| SECONDARY Smoking Habit According to Level of Asthma Control. |
7; 5; 25; 28; 23; 12 | 0.217 |
| SECONDARY Obesity According to Level of Asthma Control. |
28; 25; 27; 20 | 0.643 |
| SECONDARY Rhinitis According to Level of Asthma Control. |
18; 21; 37; 24 | 0.155 |
| SECONDARY Sinusitis According to Level of Asthma Control. |
1; 4; 54; 41 | 0.107 |
| SECONDARY Gastroesophageal Reflux According to Level of Asthma Control. |
2; 0; 53; 45 | 0.196 |
| SECONDARY Concomitant Psychiatric Disorders According to Level of Asthma Control. |
7; 2; 48; 43 | 0.150 |
| SECONDARY Pulmonary Function Test (Spirometry) According to Level of Asthma Control. |
84.23; 94.93 | 0.003 sig |
| SECONDARY Asthma Severity According to Level of Asthma Control. |
24; 31; 31; 14 | 0.013 sig |
Eligibility Criteria
Inclusion Criteria
Patients with a diagnosis of asthma according to the Global Initiative for Asthma (GINA)guideline criteria .
Exclusion Criteria
- Patients with a history of chronic obstructive pulmonary disease (COPD), residual pulmonary lesions or bronchiectasis seen on simple chest x-ray.
- Presence of another associated acute or chronic inflammatory disease.
Data sourced from ClinicalTrials.gov (NCT01455545). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.